Literature DB >> 11699420

Myasthenia gravis and lymphoblastic lymphoma involving the thymus: a rare association.

A H Uner1, H Abali, H Engin, A Akyol, S Ruacan, E Tan, I Güllü, K Altundağ, N Güler.   

Abstract

Myasthenia gravis (MG) is an autoimmune neuromuscular junction disease. An association between thymic epithelial neoplasms and MG is well known. However, it is rarely associated with hematologic malignancies. In particular, very few cases of lymphoblastic lymphoma involving the thymus and MG have been reported. Here we report a case T-cell lymphoblastic lymphoma involving the thymus who developed MG after the initial diagnosis. The patient initially presented with a mediastinal mass which was diagnosed as lymphoblastic lymphoma. MG was diagnosed during leukemic relapse in this patient and was based on clinical presentation and neurophysiologic studies including single fiber electromyography (EMG) and repetitive nerve stimulation tests. In contrast to the other cases with such an association, the myasthenic symptoms presented nine months after the diagnosis of lymphoma by thymectomy. The patient had a highly aggressive clinical course and was resistant to various chemotherapy regimens.

Entities:  

Mesh:

Year:  2001        PMID: 11699420     DOI: 10.3109/10428190109064612

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  3 in total

1.  Mediastinal neoplasms in patients with Graves disease: a possible link between sustained hyperthyroidism and thymic neoplasia?

Authors:  Jonathan D Boyd; Ridas Juskevicius
Journal:  Thyroid Res       Date:  2012-07-23

2.  Myasthenia Gravis and Large Granular Lymphocytic Leukemia: a rare association.

Authors:  Yumeng Zhang; Christa Varnadoe; Ankita Tandon; Peter Forsyth; Rami Komrokji; Lubomir Sokol
Journal:  Leuk Res Rep       Date:  2020-10-06

3.  Myasthenia Gravis Complicated with Peripheral T-cell Lymphoma, Not Otherwise Specified (PTCL-NOS), Following Thymectomy and Longstanding Tacrolimus Therapy.

Authors:  Masahiro Ohara; Kokoro Ozaki; Takuya Ohkubo; Akane Yamada; Yoshiyuki Numasawa; Keisuke Tanaka; Shohei Tomii; Satoru Ishibashi; Nobuo Sanjo; Takanori Yokota
Journal:  Intern Med       Date:  2017-12-21       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.